INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, vol.21, no.4, pp.206-210, 2006 (SCI-Expanded)
Background: Venous thromboembolism (VT) increases mortality and morbidity in cancer patients. The primary aim of this study was to evaluate the effect of VT on the survival of cancer patients and its relationship with serum vascular endothelial growth factor (VEGF) and plasma factor VIII levels.